New Study Points to Blood Testing for Food Intolerance as Important Tool in Obesity Fight
University of Miami Miller School of Medicine Report Supports Value of
Food Intolerance Testing
TORONTO, March 22, 2012 /PRNewswire/ – Gemoscan Canada, Inc. (TSXV: GES) (MUN:
1GE) welcomes a new study published in the Journal of Obesity & Weight Loss Therapy that points to food sensitivity as a key culprit in obesity. The study,
led by John E. Lewis, Ph.D., Associate Professor of Psychiatry and
Behavioral Sciences and Associate Director of the Medical Wellness
Center at the University of Miami Miller School of Medicine, and
co-authored by Judi M. Woolger, M.D., Assistant Professor of Medicine,
and Janet Konefal, Ph.D., Associate Professor of Psychiatry and
Behavioral Sciences and Assistant Dean for Complementary and
Integrative Medicine assessed the impact of a food sensitivity test “in
combination with a food elimination diet – on weight, body mass index,
and quality of life in people who wanted to lose weight and/or were
overweight,” according to published reports.
Significantly, the study suggests that a person’s food intolerances can
be identified by a simple blood test.
The HEMOCODE(TM) Food Intolerance System, available at Rexall(tm/md) and Pharma Plus stores across Canada, as well as online and via medical
professionals, is a comprehensive naturopathic nutrition program to
help Canadians identify and manage food sensitivities.
The process begins with a simple non-invasive finger stick test. Using
a drop of blood, the system scans the blood for immuno-based reactions
to common foods and additives.
“According to the study from the University of Miami, subjects lost
approximately one pound per week after eliminating foods that they
reacted to,” said Dr. Mubina Jiwa, Assistant Professor at the Canadian
College of Naturopathic Medicine. “In my practice, I find that patients
with identified food intolerances via a system such as HEMOCODE(TM) not only lose weight, but can manage a series of health issues ranging
from migraines to digestive discomfort. There is no question that
certain foods cause immuno-based responses in a large percentage of the
The HEMOCODE(TM) Food Intolerance System is more than a test; it delivers a personalized
program to insure food sensitivity results are not simply left to the
individual for interpretation and implementation. Pharmacists and
health care practitioners, under supervision of licensed Doctors of
Naturopathic Medicine, will explain and guide each person through the
various elements of the HEMOCODE(TM)system. Following the laboratory blood evaluation, personalized reports
detailing potentially offending foods and suggestions for their
elimination and substitution are returned to the pharmacist or
practitioner within 7-10 business days, for review and discussion with
each individual. Personalized recipes, as well as specific vitamin and
supplement recommendations form part of HEMOCODE(TM)’s unique, comprehensive and balanced approach to diet and food
Understanding the cause and effect of food intolerances and making the
necessary dietary adjustments, can make it easier to maintain a healthy
and active lifestyle.
The Miller School study tested 115 foods on 120 subjects aged 18 and
Study subjects who were administered a blood test to determine potential
food intolerances were then asked to eliminate the offending foods from
their diets for varying periods of time over the course of 3 months.
The study found that in addition to “positive changes associated with
body composition, participants noted substantial subjective
improvements in both physical and mental quality of life.”
Dr. Jiwa added, “These findings are consistent with what I’ve seen in my
practice, and thousands of people who use food intolerance analysis as
a way to manage overall wellness. Often, people can re-introduce the
foods that they are intolerant to after the body has a chance to
recover. I’m pleased that there are more studies being done to promote
this important wellness tool.”
Nearly 30% of the population suffers from food intolerances and
sensitivities. Dr. Jiwa warns that “self-diagnosis” can often lead to
the removal of important nutrients from a diet and suggests seeing your
health care practitioner on a regular basis.
For more information please visit www.hemocode.com.
ABOUT THE HEMOCODE(TM) FOOD INTOLERANCE SYSTEM
The HEMOCODE(TM) Food Intolerance System is a personalized naturopathic nutritional
program that promotes dietary well-being. It uses patented technology
and services to provide consultation and recommendations to simplify
the management of food sensitivities. The HEMOCODE(TM) Food Intolerance System is one of a growing number of wellness services
and products offered by pharmacies as complementary medical choices.
Complementary medicine is an adjunct to conventional medical practice,
incorporating alternative modalities and therapies with a focus on
lifestyle and wellness. A statistically significant base of
practitioners and those using HEMOCODE(TM) report improved dietary wellness and satisfaction.
ABOUT GEMOSCAN CANADA, INC.
Founded in 2003, Gemoscan Canada, Inc. owns and markets the HEMOCODE(TM) Food Intolerance System, a personalized naturopathic nutritional
program that uses its own patented technology and services to detect
and provide recommendations for the management of immuno-based food
intolerances. The HEMOCODE(TM) Food Intolerance System was designed to take the guesswork out of
deciphering what variety of common foods and additives can potentially
offend and adversely affect personal wellness. Customer-specific
reports, nutritional guidelines and recipe books are accompanied by
consultation with health-care specialists.
Gemoscan trades on the Toronto Venture Stock Exchange under the symbol
GES and is quoted on the Munich Stock Exchange under the ticker 1GE.
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this media
This news release contains certain “forward-looking information”. All
statements, other than statements of historical fact that address
activities, events or developments that Gemoscan believes, expects or
anticipates will or may occur in the future. These forward-looking
statements reflect the current expectations or beliefs of Gemoscan
based on information currently available to Gemoscan. Forward-looking
statements are subject to a number of significant risks and
uncertainties and other factors that may cause the actual results of
Gemoscan to differ materially from those discussed in the
forward-looking statements, and even if such actual results are
realized or substantially realized, there can be no assurance that they
will have the expected consequences to, or effects on Gemoscan. Any
forward-looking statement speaks only as of the date on which it is
made and, except as may be required by applicable securities laws,
Gemoscan disclaims any intent or obligation to update any
forward-looking statement, whether as a result of new information,
future events or results or otherwise. Although Gemoscan believes that
the assumptions inherent in the forward-looking statements are
reasonable, forward-looking statements are not guarantees of future
performance and accordingly undue reliance should not be put on such
statements due to the inherent uncertainty therein.
SOURCE Gemoscan Canada, Inc.